Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model.

Villadsen LS, Schuurman J, Beurskens F, Dam TN, Dagnaes-Hansen F, Skov L, Rygaard J, Voorhorst-Ogink MM, Gerritsen AF, van Dijk MA, Parren PW, Baadsgaard O, van de Winkel JG.

J Clin Invest. 2003 Nov;112(10):1571-80.

2.

Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.

Breukels MA, Rijkers GT, Voorhorst-Ogink MM, Zegers BJ, Sanders LA.

J Infect Dis. 1999 May;179(5):1152-6.

PMID:
10191217
3.

Regulatory T cells in the antibody response to Haemophilus influenzae type b polysaccharide.

Breukels MA, Rijkers GT, Voorhorst-Ogink MM, Zegers BJ.

Infect Immun. 1999 Feb;67(2):789-93.

4.

Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent bacterial respiratory tract infections.

Sanders LA, Rijkers GT, Tenbergen-Meekes AM, Voorhorst-Ogink MM, Zegers BJ.

Pediatr Res. 1995 Jun;37(6):812-9.

PMID:
7651768
5.

Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis.

de Graeff-Meeder ER, van Eden W, Rijkers GT, Prakken BJ, Kuis W, Voorhorst-Ogink MM, van der Zee R, Schuurman HJ, Helders PJ, Zegers BJ.

J Clin Invest. 1995 Mar;95(3):934-40.

6.

Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils.

Sanders LA, Feldman RG, Voorhorst-Ogink MM, de Haas M, Rijkers GT, Capel PJ, Zegers BJ, van de Winkel JG.

Infect Immun. 1995 Jan;63(1):73-81.

7.

Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections.

Sanders LA, van de Winkel JG, Rijkers GT, Voorhorst-Ogink MM, de Haas M, Capel PJ, Zegers BJ.

J Infect Dis. 1994 Oct;170(4):854-61.

PMID:
7930727
8.

Antibodies to human HSP60 in patients with juvenile chronic arthritis, diabetes mellitus, and cystic fibrosis.

de Graeff-Meeder ER, Rijkers GT, Voorhorst-Ogink MM, Kuis W, van der Zee R, van Eden W, Zegers BJ.

Pediatr Res. 1993 Oct;34(4):424-8.

PMID:
8255671
9.

Fc gamma IIA receptor phenotype and opsonophagocytosis in two patients with recurrent bacterial infections.

Sanders EA, Van de Winkel JG, Feldman RG, Voorhorst-Ogink MM, Rijkers GT, Capel PJ, Zegers BJ.

Immunodeficiency. 1993;4(1-4):163-5. No abstract available.

PMID:
8167694
10.

Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis.

Boog CJ, de Graeff-Meeder ER, Lucassen MA, van der Zee R, Voorhorst-Ogink MM, van Kooten PJ, Geuze HJ, van Eden W.

J Exp Med. 1992 Jun 1;175(6):1805-10.

11.

Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids.

Veldscholte J, Voorhorst-Ogink MM, Bolt-de Vries J, van Rooij HC, Trapman J, Mulder E.

Biochim Biophys Acta. 1990 Apr 9;1052(1):187-94.

PMID:
2322591
12.

Characterization of polyclonal antibodies against the N-terminal domain of the human androgen receptor.

van Laar JH, Voorhorst-Ogink MM, Zegers ND, Boersma WJ, Claassen E, van der Korput JA, Ruizeveld de Winter JA, van der Kwast TH, Mulder E, Trapman J, et al.

Mol Cell Endocrinol. 1989 Nov;67(1):29-38.

PMID:
2482209
13.

The human androgen receptor is a 110 kDa protein.

van Laar JH, Bolt-de Vries J, Voorhorst-Ogink MM, Brinkmann AO.

Mol Cell Endocrinol. 1989 May;63(1-2):39-44.

PMID:
2787763

Supplemental Content

Loading ...
Support Center